Our Specialists

Dr Scott Davison is a Staff Specialist at the Liverpool Hospital and a conjoint lecturer at the University of NSW. He completed his medical degree at the University of Sydney in 2004, and worked as a junior doctor at Wollongong and Royal Prince Alfred Hospital. He completed Fellowship of the Royal Australasian College of Physicians (FRACP) in 2010 with specialist training in Gastroenterology and Hepatology at Liverpool Hospital. He has worked as a staff specialist at Liverpool Hospital since that time, and was the Network Director of Physician Training for the Liverpool Network for three years during this period.

Dr Davison is dedicated to the provision of high quality medical care to a broad population of the community with a focus on liver health, cancer prevention and management, and viral hepatitis. He has extensive clinical experience in chronic viral hepatitis B and C, and contributes to clinical research in the management of these conditions. He has been an educator and speaker in various capacities in relation to these topics, with a particular interest in chronic viral hepatitis in Indigenous Australians.

In addition to his work in hepatology, Dr Davison contributes to inpatient and outpatient gastroenterology at Liverpool Hospital with expertise in gastroscopy and colonoscopy, inflammatory bowel disease and functional gastrointestinal issues.

MBBS
University of Sydney 2004

FRACP
Royal Australian College of Physicians 2011

Ph.D. in Medicine Dissertation
University of New South Wales (in progress)
Epidemiology and outcomes of management of Hepatocellular Carcinoma in NSW since 2001

BA Hons
University of Sydney 1994

Staff Specialist, Gastroenterologist and Hepatologist (Jan 2012 – present)
Department of Gastroenterology and Liver, Liverpool Hospital

Network Director of Physician Education (Jan 2012 – 2015)
Liverpool Hospital

Member National Examining Panel (2016 - present)
Royal Australasian College of Physicians

Conjoint Associate Lecturer (2012 – present)
University of New South Wales

Consultant Gastroenterologist/Hepatologist (2012 - 2016)
Tharawal Aboriginal Medical Service, AIRDS

Visiting Medical Officer (2016 – present)
Chris O'Brien Lifehouse

1. Hepatitis C treatment for difficult to access populations; can telementoring (as distinct from telemedicine) help? Mohsen W, Chan P, Whelan M, Glass A, Mouton M, Yeung E, Trinh Q, Arora S, Davison S, Lama T, Cobrador C, Levy MT.
   Intern Med J. 2018 Aug 8. doi: 10.1111/imj.14072. PMID: 30091164
   
2. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing. Thilakanathan C, Wark G, Maley M, Davison S, Lawler J, Lee A, Shackel N, Nguyen V, Jackson K, Glass A, Locarnini SA, Levy MT.
   Liver Int. 2018 Jul;38(7):1212-1219. doi: 10.1111/liv.13736. Epub 2018 Mar 31. PMID:29532580
   
3. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. Greenup AJ, Tan PK, Nguyen V, Glass A, Davison S, Chatterjee U, Holdaway S, Samarasinghe D, Jackson K, Locarnini SA, Levy MT.
   J Hepatol. 2014 Sep;61(3):502-7. doi: 10.1016/j.jhep.2014.04.038. Erratum in: J Hepatol. 2015 Oct;63(4):1054. PMID: 24801414
   
4. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Nguyen V, Tan PK, Greenup AJ, Glass A, Davison S, Samarasinghe D, Holdaway S, Strasser SI, Chatterjee U, Jackson K, Locarnini SA, Levy MT. Aliment Pharmacol Ther. 2014 May;39(10):1225-34. doi: 10.1111/apt.12726. PMID: 24666381
   
5. Ordering and interpreting hepatitis B serology. Davison SA, Strasser SI. BMJ. 2014 Apr 17;348:g2522. doi: 10.1136/bmj.g2522. Review. PMID: 24742733